Efficacy and Safety of Ritalin?? LA???, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder-Reference-Cited by-同舟云学术

Efficacy and Safety of Ritalin?? LA???, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder

Published:2003 Issue:12 Volume:5 Page:833-841
ISSN:1174-5878
Container-title:Pediatric Drugs
language:en
Short-container-title:Pediatric Drugs

Author:

Biederman Joseph,Quinn Declan,Weiss Margaret,Markabi Sabri,Weidenman Meredith,Edson Kathryn,Karlsson Goeril,Pohlmann Harald,Wigal Sharon

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pediatrics, Perinatology and Child Health

Reference15 articles.

1. Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder

2. Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

3. Peer relationships in boys with attention-deficit hyperactivity disorder with and without comorbid aggression

4. The Social Profile of Attention-Deficit Hyperactivity Disorder: Five Fundamental Facets

5. Hyperactive Children Treated With Stimulants

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials;Journal of Attention Disorders;2024-04-10

2. In Memoriam: Professor Joseph Biederman’s Contributions to Child and Adolescent Psychiatry;Journal of Attention Disorders;2024-02-09

3. Adverse Events During Dosing of Delayed-release/Extended-release Methylphenidate: Learnings From the Open-label Phase of a Registration Trial and a Real-world Postmarketing Surveillance Program;Clinical Therapeutics;2023-12

4. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD);Cochrane Database of Systematic Reviews;2023-03-27

5. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders;Seminars in Cancer Biology;2022-11